EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors

Srinivasulu Cherukupalli iD, Jan Eickhoff iD, Carsten Degenhart, Peter Habenberger iD, Anke Unger iD, Bård Helge Hoff iD, Eirik Sundby

Molecules · 2025

DOI: 10.3390/molecules30122641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Srinivasulu Cherukupalli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Norwegian University of Science and Technology (NTNU), Høgskoleringen 5, NO-7491 Trondheim, Norway. Hauptthemen laut MEDLINE: Triazoles, Pyrimidines, Pyrroles, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Trond Mohn Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

6-Aryl-7H-pyrrolo[2,3-d]pyrimidin-4-amines have promising properties as colony-stimulating factor 1 receptor (CSF1R) inhibitors. Inspired by these antagonists, two series of 1,2,3-triazole analogues (28 compounds) were synthesized and evaluated as CSF1R inhibitors. Enzymatic IC50 profiling showed that 27 of the 28 derivatives had lower IC50 than the reference drug PLX-3397. Three derivatives displayed CSF1R Ba/F3 cellular IC50 well below 1 µM. Profiling of the most promising triazole analogue (compound 27a) toward a panel of kinases reveals a high selectivity for CSF1R with respect to its family kinases, but 27a also inhibits ABL, SRC, and YES kinases. Molecular docking of 27a toward two CSF1R X-ray structures identified two different ligand-inverted binding poses, which triggers interest for further investigations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriazolesPyrimidinesPyrrolesReceptors, Granulocyte-Macrophage Colony-Stimulating FactorStructure-Activity RelationshipCrystallography, X-RayAnimalsMiceCell LineMolecular Docking SimulationProtein KinasesCell Survival

Stichwörter der Autor:innen

CSF1Rcopper-catalyzed azide–alkyne cycloadditionpyrrolopyrimidinetriazole

Substanzen

TriazolespyrrolopyrimidinePyrimidinesPyrrolesCsf1r protein, mouseReceptors, Granulocyte-Macrophage Colony-Stimulating FactorProtein Kinases

Autor:innen und Institutionen

  • Department of Chemistry, Norwegian University of Science and Technology (NTNU), Høgskoleringen 5, NO-7491 Trondheim, Norway.
  • Lead Discovery Center GmbH (LDC), Otto-Hahn-Strasse 15, 44227 Dortmund, Germany.
  • Department of Material Science, Norwegian University of Science and Technology (NTNU), NO-7491 Trondheim, Norway.

ORCID-Profile: Srinivasulu Cherukupalli, Jan Eickhoff, Peter Habenberger, Anke Unger, Bård Helge Hoff

Förderung

  • Trond Mohn Foundation

Zitieren

APA

Cherukupalli, S., Eickhoff, J., Degenhart, C., Habenberger, P., Unger, A., Hoff, B. H., & Sundby, E. (2025). Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors. Molecules. https://doi.org/10.3390/molecules30122641

Vancouver

Cherukupalli S, Eickhoff J, Degenhart C, Habenberger P, Unger A, Hoff BH, et al. Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors. Molecules. 2025. doi:10.3390/molecules30122641

BibTeX
@article{Cherukupalli2025,
  author = {Cherukupalli, Srinivasulu and Eickhoff, Jan and Degenhart, Carsten and Habenberger, Peter and Unger, Anke and Hoff, Bård Helge and Sundby, Eirik},
  title = {Evaluating Triazole-Substituted Pyrrolopyrimidines as CSF1R Inhibitors},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30122641}
}
Kostenlos starten →